| |
|
|
|
Vaccinex Inc.  
|
|
4.5525 0.252 (0.06%) |
03-21 12:04 |
|
Open: |
4.3 |
Pre close: |
4.3 |
Target:
|
5.47
|
|
High: |
4.65 |
Low: |
4.3 |
Resistance:
|
4.68
5.25
|
|
Volume: |
2,684 |
Market Cap: |
52M |
Support:
|
3.77
3.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.17
 |
MACD |
MACD(12,26):
|
-0.12 |
|
MA(20): |
4.25  |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
4.95 |
Stochastic Oscillator |
%K(14,3):
|
43.72 |
|
MA(250): |
0.00 |
%D(3): |
31.63 |
|
Average Volume(K) |
3-Month: |
682
|
52-Week |
High:
|
11.72 |
|
10-Days: |
1377 |
Low: |
3.32 |
|
RSI |
RSI(14):
|
53.22 |
Change(%): |
-60.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
41.7 |
Shares Out. (M) |
11.48 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-213.9 |
Shares Float (M) |
11.45 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.90 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.97 |
P/S |
215250000.00 |
|
Operating Margin |
-4018.87 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-2.15 |
|
|
|
|
|
|
